Exercise Training in Obesity-prone Black and White Women

November 16, 2017 updated by: Gary Hunter, PhD, University of Alabama at Birmingham
Overweight premenopausal Black and White women are randomized to either diet-only, diet+aerobic or diet+resistance exercise training. Diet/behavior intervention, with or without the aerobic or resistance exercise training, will be provided throughout the 18 months of study. Major outcomes will include measures of perceived and physiologic difficulty of exercise (cardiac, ventilatory, electromyographic responses to standardized exercise tasks); aerobic fitness; strength fitness; and spontaneous free-living energy expenditure (all derived from doubly labeled water). The results will provide insight into the effectiveness of, and the mechanisms by which, different types of exercise training can improve physical fitness, spontaneous engagement in physical activities of daily living and, in turn, weight-loss maintenance.

Study Overview

Detailed Description

Overweight premenopausal Black and White women are randomized to either diet-only, diet+aerobic or diet+resistance exercise training. Diet/behavior intervention, with or without the aerobic or resistance exercise training, will be provided throughout the 18 months of study. Major outcomes will include measures of perceived and physiologic difficulty of exercise (cardiac, ventilatory, electromyographic responses to standardized exercise tasks); aerobic fitness; strength fitness; and spontaneous free-living energy expenditure (all derived from doubly labeled water). The results will provide insight into the effectiveness of, and the mechanisms by which, different types of exercise training can improve physical fitness, spontaneous engagement in physical activities of daily living and, in turn, weight-loss maintenance.

Time of initial weight loss was defined as the time needed to reach the goal of 25 kg/m2 BMI. The women will then be evaluated one year after this time and the amount of weight gain will be determined.

Study Type

Interventional

Enrollment (Actual)

231

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35294
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 41 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

  • Normoglycemic
  • BMI between 27-30
  • Non smoker
  • Premenopausal
  • Physically untrained
  • Family history of obesity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Diet only
Experimental: Diet plus aerobic exercise
Experimental: Diet plus resistance exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight loss
Time Frame: 6 months
6 months
Change in weight after initial weight loss
Time Frame: 12 months after initial weight loss (maximum 18 months after randomization)
Time of initial weight loss determined by days to reach BMI <= 25 (maximum 6 months)
12 months after initial weight loss (maximum 18 months after randomization)

Secondary Outcome Measures

Outcome Measure
Time Frame
Insulin sensitivity
Time Frame: 6 months post baseline
6 months post baseline
Insulin sensitivity
Time Frame: 18 months post baseline
18 months post baseline
Change in visceral fat
Time Frame: 6 months post baseline
6 months post baseline
Change in visceral fat
Time Frame: 18 months post baseline
18 months post baseline
Change in cholesterol
Time Frame: 6 months post baseline
6 months post baseline
Change in cholesterol
Time Frame: 18 months post baseline
18 months post baseline
Change in triglycerides
Time Frame: 6 months post baseline
6 months post baseline
Change in triglycerides
Time Frame: 18 months post baseline
18 months post baseline
Change in resting energy expenditure
Time Frame: 6 months post baseline
6 months post baseline
Change in resting energy expenditure
Time Frame: 18 months post baseline
18 months post baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gary R Hunter, PhD, University of Alabama at Birmingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2000

Primary Completion (Actual)

December 1, 2007

Study Completion (Actual)

December 1, 2007

Study Registration Dates

First Submitted

August 29, 2003

First Submitted That Met QC Criteria

August 29, 2003

First Posted (Estimate)

September 1, 2003

Study Record Updates

Last Update Posted (Actual)

November 20, 2017

Last Update Submitted That Met QC Criteria

November 16, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • BLKWHT (DK49779) (completed)
  • R01DK049779 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Diet

Subscribe